But in the early 2000s, researchers began showing how companies could manipulate images and audio to de-emphasize safety information. In one example, a Duke University professor found that ads for the ...
Striving to stay sober, Hal Pyzyna succeeded for nearly a decade until the COVID-19 pandemic struck in 2020 — the stress ...
Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...
The U.S. patient population for Revuforj in its approved indication is roughly 2,000 according to Syndax. KMT2A leukemias ...
Grandstanding like the FDA's and the NGO's does nothing to keep consumers safe or deal with the real challenges faced by BBU ...
BTIG analyst Justin Zelin has reiterated their bullish stance on SNDX stock, giving a Buy rating on November 15.Don't Miss our Black Friday ...
Axios on MSN11h
Abortion pills may be FDA's first test under TrumpWhile the early focus on a Trump administration Food and Drug Administration has been on vaccine policy, one of its first ...
Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...
Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024PARIS, FRANCE, 18 ...
Alkeus Pharmaceuticals today announced that gildeuretinol (ALK-001), an investigational oral therapy, has received Rare ...
The new rules instruct drugmakers to use simple, consumer-friendly language when describing their drugs, without medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback